Source numbers link to evidence. [Inference] marks analytical judgment, including motion classifications and causal explanations. Public evidence does not establish every internal decision or metric.
Conceptual illustration for 01Health: a medical cross, modular grid, and connected nodes compose a small visual study of care infrastructure.
- Company
- 01Health · Healthcare infrastructure · 01health.ai
- Conversion motions
- [Inference] This research classifies 01Health as Human Led and Partner Led.
- 01Health beachhead and target customer
- [Inference] Practices and dental groups extending specialist care through local providers.
- Product and buying complexity
- [Inference] Clinical oversight, training, procurement and patient workflows make this more complex than a software-seat purchase.
- Market at entry
- [Unverified] This focused brief does not establish the full market conditions at first sale.
- Evidence
- Evidence brief · 1 linked source · research date · method and limitations
The ten-step Revenue Engine reading map
These links locate relevant evidence. A linked section does not imply every detail of the step is publicly established.
- Acquire Your First Customers: Founder Led Sales Read first customers
- Embrace GTM Experimentation Read experiments & lessons
- Understand Your GTM Motion Options Read GTM motion
- Pick Your GTM Motion Not established in this entry
- Generate a Lead Read GTM motion · Read experiments & lessons
- Turn Leads into Paying Customers Read GTM motion
- Retain and Grow Your Customers Read retain & expand
- Build Your GTM Team Not established in this entry
- Plan Your Tech Stack Read experiments & lessons
- Optimize and Scale Through Metrics Not established in this entry
01Health: Origin and evidence boundary
The first paid customer and founder closing sequence were not established in this focused evidence brief.
Gresham House describes 01Health as founded in 2022 by former NHS doctor Dr Sonia Szamocki. Its technology first supported owned dental platforms 32Co and Aerox Health. The investment account describes opening that infrastructure to practices and dental groups, with US trials and a newly appointed commercial lead whose name is not given. [1]
[1]01Health: Motion and buyer logic
[Inference] Practices and dental groups extending specialist care through local providers.
[Inference] Clinical oversight, training, procurement and patient workflows make this more complex than a software-seat purchase.
[1]01Health: Retention and expansion hypothesis
[Inference] More practices and specialist service lines can widen deployment, subject to delivery capacity and oversight.
[Unverified] Individual CSM ownership, enablement conversion and renewal cohorts were not established in this brief.
01Health: Critical reading
[Inference] Internal operations can provide a test bed for a platform. External licensing needs repeatable onboarding and a clear boundary between technology, clinical responsibility and commercial incentives.
[Unverified] The inspected material does not establish failed-channel experiments or a complete causal account of growth.
01Health economics at a glance: Pricing is only half the story.
Exact current pricing was not verified in this brief.
[Inference] More practices and specialist service lines can widen deployment, subject to delivery capacity and oversight.
[Inference] Internal operations can provide a test bed for a platform. External licensing needs repeatable onboarding and a clear boundary between technology, clinical responsibility and commercial incentives.
Not publicly verified in this brief.
Not publicly verified in this brief.
The people in the 01Health GTM story: People & capabilities.
Dr Sonia Szamocki
People identified in the sourceDr Sonia Szamocki — founder and former NHS doctor.
See the source-backed account above; additional skills and training are not inferred as fact.
[1]01Health GTM: critical reading and analysis: Why it worked.
Where it breaks.
What worked—and why
[Inference] Internal operations can provide a test bed for a platform. External licensing needs repeatable onboarding and a clear boundary between technology, clinical responsibility and commercial incentives.
What did not work
No substantiated failed experiment established in the inspected evidence.
What could have been better
[Inference] Validate the proposed growth mechanism with paid conversion, implementation cost and retained customer outcomes.
What another founder can use
[Inference] More practices and specialist service lines can widen deployment, subject to delivery capacity and oversight.
01Health go-to-market FAQ: The questions that matter.
What does this case establish about 01Health?
The inspected source supports the specific product, people or distribution facts in the origin section; a full chronological reconstruction remains incomplete. [1]
Is the full GTM history of 01Health verified?
No. This is a focused evidence brief. The page distinguishes inspected claims from analytical hypotheses and lists the remaining gaps.
Which go-to-market motions is 01Health classified under?
[Inference] This research classifies 01Health as Human Led and Partner Led. Motion labels describe routes across segments and periods, not measured revenue shares.
01Health sources and open questions: Follow the sources.
- Gresham House Ventures — inspected company evidence Gresham House Ventures · primary
Origin, product, team or current commercial route described in the source; narrower claims are attributed in the text.
What remains unverified
Evidence brief rather than a full historical GTM reconstruction.
First contracts, complete hiring sequence, pricing history, CAC and retention require further source verification.
No historical website screenshot or named account expansion is represented as verified.
No verified visual capture is attached to this entry. A current screenshot is not a substitute for a historical capture.
